Immunomodulation of experimental murine herpes simplex keratitis: II. Glycoprotein D protection

References

• Spear P. G. Membrane proteins specified by herpes simplex viruses.I. Identification of four glycoprotein precursors and their products in type 1-infected cells. J. Virol. 1976; 17: 991–1008
   Google Scholar
• Courtney R. J. Virus specific components of herpes simplex virus involved in the immune response. “Immunobiology of Herpes Simplex Virus Infection”, B. T. Ruse, C. Lopez. CRC Press, Boca Raton, FL 1984; 33–44
   Google Scholar
• Vestergaard B. F., Norrild B. Crossed immunoelectrophoretic analysis and virus neutralizing activity of five monospecific antisera against five different herpes simplex virus glycoproteins. I.A.R.C. Sci. Publ. 1979; 24: 225–234
   Google Scholar
• Pereira L., Klassen T., Baringer J. R. Type-common and type-specific monoclonal antibody to herpes simplex virus type 1. Infect. Immun. 1980; 29: 724–732
   PubMed Web of Science ®Google Scholar
• Long D., Madara T. J., Ponce de Leon M., Cohen G. H., Montgomery P. C., Eisenberg R. J. Glycoprotein D protects mice against lethal challenge with herpes simplex virus types 1 and 2. Infect. Immun. 1984; 43: 761–764
   PubMed Web of Science ®Google Scholar
• Eisenberg R. J., Cerini C. P., Heilman C. J., Joseph A. D., Dietzschold B., Golub E., Long D., Ponce de Leon M., Cohen G. H. Synthetic glycoprotein D-related peptides protect mice against herpes simplex virus challenge. J. Virol. 1985; 56: 1014–1017
   PubMed Web of Science ®Google Scholar
• Sandstrom I. K., Foster C. S., Wells P. A., Knipe D., Caron L., Greene M. I. Previous immunization of mice with herpes simplex virus type-1 strain MP protects against secondary corneal infection. Clin. Immunol. Immunopathol. 1986; 40: 326–334
   PubMedGoogle Scholar
• Thompson P., Wells P. A., Sandstrom I. K., Opremcak E. M., Millin J. A., Daigle J., Foster C. S. Immunomodulation of experimental murine herpes simplex keratitis: I. Subcutaneous immunization with UV inactivated herpes simplex virus protects againt keratitis and latency following corneal HSV-1 challenge. Current Eye Res., 7: 1043–1049
   PubMedGoogle Scholar
• Zweig M., Heilman C. J., Bladen S. V., Showalter S. D., Hampar B. Detection in antisera of antibodies that cross-react with herpes simplex virus type 1 glycoprotein gC. Infect. Immun. 1983; 41: 482–487
   PubMedGoogle Scholar
• Hampar B., Zweig M., Showalter S. D., Bladen S. V., Riggs C. W. Enzyme linked immunosorbent assay for determination of antibodies against herpes simplex virus types 1 and 2 in human sera. J. Clin. Microbiol. 1985; 21: 496–500
   PubMedGoogle Scholar
• Rosenberg G. L., Farber P. A., Montkins A. L. In Vitro stimulation of sensitized lymphocytes by herpes simplex virus and vaccinia virus. P.N.A.S., USA 1972; 69: 756–760
   PubMed Web of Science ®Google Scholar
• Foster C. S., Tsai Y., Monroe J. G., Campbell R., Cestari M., Wetzig R., Knipe D., Greene M. I. Genetic studies on murine susceptibility to herpes simplex keratitis. Clin. Immunol. Immunopathol. 1986; 40: 313–325
   PubMedGoogle Scholar
• Tullo A. B., Shimeld C., Blyth A., Hill T. J., Easty D. L. Ocular infection with herpes simplex virus in nonimmune and immune mice. Arch. Ophthalmol. 1983; 101: 961–964
   PubMedGoogle Scholar
• Skinner G. R.B., Woodman C, Hartley C, Buchan A., Fuller A., Wiblin C, Wilkins G., Melling J. Early experience with “antigenoid” vaccine Ac NFU (S-) MRC towards prevention or modification of herpes genitalis. “17th Intl. Congress on Herpes Virus of Man and Animal: Standardization of Immunological Procedures”. LyonFrance 1982; 333–334, 1981, Dev. Biol. Stand.
   Google Scholar
• Carter C. A., Hartley C. E., Skinner G. R.B., Turner S. P., Eastey D. L. Preliminary observations on the efficacy of herpes simplex virus subunit vaccine. Br. J. Ophthalmol. 1981; 65: 679–681
   PubMedGoogle Scholar
• Berman P. W., Gregory T., Crase D., Lasky L. A. Protection from genital herpes simplex type 2 infection by vaccination with cloned type 1 glycoprotein D. Science 1985; 227: 1490–1492
   PubMed Web of Science ®Google Scholar
• Bal E. E., Puricelli L., DelaPena N. D., DeLustig E. S. Influence of human leukocyte interferon in IgG on the replication of herpes simplex virus in nervous tissues in vitro. Acta Virol. 1979; 23: 461–467
   PubMedGoogle Scholar
• Ecob-Johnston M. S., Whetsell W. O. Host cell response to herpes virus infection in central and peripheral nervous tissue in vitro. J. Gen. Virol. 1979; 44: 747–757
   PubMedGoogle Scholar
• Kino Y., Hayashi Y., Hayashida I., Mori R. Dissemination of herpes simplex virus in nude mice after intracutaneous inoculation and effective antibody on the course of infection. J. Gen. Virol. 1982; 63: 475–479
   PubMedGoogle Scholar
• Klein R. J. Effect of immune serum on the establishment of herpes simplex virus infection in trigeminal ganglia of hairless mice. J. Gen. Virol. 1980; 45: 401–405
   Google Scholar
• Kristensson K., Vahlne A., Persson L. A., Lycke E. Neural spread of herpes simplex virus types 1 and 2 in mice after cornel or subcutaneous (footpad) inoculation. J. Neurol. Sci. 1978; 35: 331–340
   PubMedGoogle Scholar
• Oakes J. E., Davis W. B., Taylor J. A., Weppner W. A. Lymphocyte reactivity contributes to protection conferred by specific antibody passively transferred to herpes simplex virus infected mice Infect. Immun. 1980; 29: 642–649
   Google Scholar
• Stevens J. G., Cook M. L. Maintenance of latent herpetic infection: apparent role for antiviral IgG. J. Immunol. 1974; 113: 1685–1693
   PubMed Web of Science ®Google Scholar
• Openshaw H., Asher S., Wohlenberg C., Sekizaha T., Notkins A. L. Acute and latent infection of sensory ganglia with herpes simplex virus: immune control and virus reactivation. J. Gen. Virol. 1979; 44: 205–215
   PubMed Web of Science ®Google Scholar
• Openshaw H. +, Puga A., Notkins A. L. Herpes simplex virus infection in sensory ganglia: immune control, latency and reactivation. Fed. Proc. 1979; 38: 2660–2664
   PubMedGoogle Scholar
• Rajcani J., Clampor F., Sabo A., Libikova H., Rosenbergova M. Activation of latent herpes virus hominis in explants of rabbit trigeminal ganglia: the influence of immune serum. Arch. Virol. 1977; 53: 55–69
   PubMedGoogle Scholar
• Walz M. A., Yamamoto H., Notkins A. L. Immunological response restricts number of cells in sensory ganglia infected with herpes simplex virus. Nature (London) 1976; 264: 554–556
   PubMed Web of Science ®Google Scholar
• Fuller A. O., Spear P. G. Specificities of monoclonal and polyclonal antibodies that inhibit adsorption of herpes simplex virus to cells and back of inhibition by potent neutralizing antibodies. J. Virol. 1985; 55: 475–482
   PubMed Web of Science ®Google Scholar
• Oakes J. E., Lausch R. N. Monoclonal antibodies suppress replication of herpes simplex virus type 1 in trigeminal ganglia. J. Virol. 1984; 51: 656–661
   PubMed Web of Science ®Google Scholar